LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
22.50
+0.10 (0.45%)
Jan 17, 2025, 4:00 PM EST - Market closed
LENZ Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for LENZ Therapeutics stock have an average target of 35.4, with a low estimate of 32 and a high estimate of 38. The average target predicts an increase of 57.33% from the current stock price of 22.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 7, 2024.
Analyst Ratings
The average analyst rating for LENZ stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +68.89% | Nov 7, 2024 |
| Raymond James | Raymond James | Buy Initiates $37 | Buy | Initiates | $37 | +64.44% | Sep 27, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $36 | Buy | Maintains | $36 | +60.00% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +68.89% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +68.89% | Aug 12, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
9.06M
EPS This Year
-3.03
from -7.22
EPS Next Year
-2.39
from -3.03
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | 12.9M | 66.4M |
| Avg | n/a | 9.1M | 53.1M |
| Low | n/a | 5.9M | 40.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 632.8% |
| Avg | - | - | 486.0% |
| Low | - | - | 351.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.91 | -1.25 | -1.40 |
| Avg | -3.03 | -2.39 | -2.23 |
| Low | -4.66 | -3.06 | -2.76 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.